Alturki, M.; Alshehri, A.A.; Aldossary, A.M.; Fallatah, M.M.; Almughem, F.A.; Al Fayez, N.; Majrashi, M.A.; Alradwan, I.A.; Alkhrayef, M.; Alomary, M.N.;
et al. Unconventional Immunotherapies in Cancer: Opportunities and Challenges. Pharmaceuticals 2025, 18, 1154.
https://doi.org/10.3390/ph18081154
AMA Style
Alturki M, Alshehri AA, Aldossary AM, Fallatah MM, Almughem FA, Al Fayez N, Majrashi MA, Alradwan IA, Alkhrayef M, Alomary MN,
et al. Unconventional Immunotherapies in Cancer: Opportunities and Challenges. Pharmaceuticals. 2025; 18(8):1154.
https://doi.org/10.3390/ph18081154
Chicago/Turabian Style
Alturki, Meshael, Abdullah A. Alshehri, Ahmad M. Aldossary, Mohannad M. Fallatah, Fahad A. Almughem, Nojoud Al Fayez, Majed A. Majrashi, Ibrahim A. Alradwan, Mohammad Alkhrayef, Mohammad N. Alomary,
and et al. 2025. "Unconventional Immunotherapies in Cancer: Opportunities and Challenges" Pharmaceuticals 18, no. 8: 1154.
https://doi.org/10.3390/ph18081154
APA Style
Alturki, M., Alshehri, A. A., Aldossary, A. M., Fallatah, M. M., Almughem, F. A., Al Fayez, N., Majrashi, M. A., Alradwan, I. A., Alkhrayef, M., Alomary, M. N., & Tawfik, E. A.
(2025). Unconventional Immunotherapies in Cancer: Opportunities and Challenges. Pharmaceuticals, 18(8), 1154.
https://doi.org/10.3390/ph18081154
